NCT05857189

Brief Summary

A straightforward, user-friendly removable orbital prosthesis is a practical choice for effective rehabilitation in such patients with defective eyes. One of the essential elements for a good recovery is the retention of the prosthesis. The prosthesis can be retained by using a spectacle frame, conformers, adhesives, osseointegrated implants, magnets, or buttons. Only osseointegrated prostheses in the maxillofacial region can use semi-precision attachments.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2023

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 2, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 12, 2023

Completed
18 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2023

Completed
Last Updated

May 12, 2023

Status Verified

May 1, 2023

Enrollment Period

5 months

First QC Date

April 2, 2023

Last Update Submit

May 10, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in quality of life score

    each person's medical chart. Participants will complete the Arabic version of the World Health Organization Quality of Life Instrument, Short Form (WHOQOL-BREF) before and after intervention. The 26- item WHOQOL-BREF Arabic version consists of two overall items measuring general QOL and health condition and 24 items that are universally adopted for the WHOQOL-BREF in four domains: physical health, psychological health, social relationships, and environment. Each item will be rated on a 5- point Likert scale and the domain scores were transformed on a scale from 0 to 100

    Through study completion, average 6 months

  • Patient behaviour toward using the newly designed eye glasses

    The 14-item visual function questionnaire (VF-14), is based on 14 vision-dependent activities performed in everyday life, and the difficulty undertaking each activity is rated Scores range from 0 to 100, and higher scores represent better visual functioning and less difficulty to perform daily activities.

    Through study completion, average 6 months

Study Arms (3)

Experimental group

EXPERIMENTAL
Device: Digitalized printed paper

Control group

ACTIVE COMPARATOR
Device: Traditional drawing image

Healthy control group

OTHER

patients in this group will be observed as a normal reference group

Other: Healthy controls

Interventions

Patients will receive a newly formed digitalized printed paper inserted into eyeglasses

Experimental group

Patients will receive eyeglasses that hold a traditional drawing image of the eye

Control group

Patients will include volunteering participants with un defected eye

Healthy control group

Eligibility Criteria

Age6 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with an orbital defective eye (type I).
  • Patients age more than 6 years.
  • Patients with a unilateral enucleated eye.
  • Skin-grafted orbital defects with a lack of natural retentive means either natural undercuts or retaining implants.
  • Patients who are not prone to be received any prosthetic rehabilitation either for financial, age, or transportation problems of material that are needed for fabrication of prosthetic eye.

You may not qualify if:

  • Patients with the bilateral enucleated eye.
  • Patients with primary signs of skin inflammation, infection, or untreated local disease
  • Patients refusing to wear any eyeglasses.
  • Patients with ocular defects.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Alexandria Faculty of Dentistry

Alexandria, Egypt

RECRUITING

Central Study Contacts

Ahmed k Farag, BDS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Crossover between experimental and traditional groups after 2 weeks of lapse time. both groups will be compared to healthy control
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assistant lecturer of DPH and Clinical statistician

Study Record Dates

First Submitted

April 2, 2023

First Posted

May 12, 2023

Study Start

January 1, 2023

Primary Completion

May 30, 2023

Study Completion

May 30, 2023

Last Updated

May 12, 2023

Record last verified: 2023-05

Locations